Benchmark analyst Mark Zgutowicz initiates coverage on Stagwell (NASDAQ:STGW) with a Buy rating and announces Price Target of $15.
Analyst Expectations for Zentalis Pharma’s Future
Within the last quarter, Zentalis Pharma (NASDAQ:ZNTL) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…